ANKTIVA
NDC 81481-803, nogapendekin alfa inbakicept-pmln, solution, from Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc..
- Product NDC
- 81481-803
- Status
- Listed
- Labeler
- Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.
- Dosage form
- SOLUTION
- Route
- INTRAVESICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761336
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81481-803 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NOGAPENDEKIN ALFA INBAKICEPT-PMLN400 ug/.4mL
Pharmacologic classes
Interleukin-15 Receptor Agonist [EPC]; Interleukin-15 Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81481-803-01 | 81481080301 | 1 VIAL, GLASS in 1 BOX (81481-803-01) / .4 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/eae31db8-3e7a-d9e0-708d-74419d1b50ffMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=81481-803
Use it
Look up 81481-803 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81481-803 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81481-803. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.